Evidence map›Paper›PMID 30414125›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2019

High-Throughput, Biosensor-Based Approach to Examine Bone Morphogenetic Protein (BMP)-Receptor Interactions.

Senem Aykul, Erik Martinez-Hackert

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Senem AykulDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA.
Erik Martinez-HackertDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA. emh@msu.edu.
Michigan State University · US

Funding

TGF-β signaling and regulation: Elucidating molecular mechanisms and pathogenic functions of the ‘co-receptor’ Cripto-1 and the receptor BMPRIIR01GM121499 · NIGMS · MICHIGAN STATE UNIVERSITY · PI MARTINEZ HACKERT, ERIK MATTHIAS · 2018 to 2022
$1.5M
Novel Activin A Antagonists for Treatment of OsteoporosisR41AR068804 · NIAMS · ABREOS BIOSCIENCES, INC. · PI MARTINEZ HACKERT, ERIK MATTHIAS, MESSMER, BRADLEY T · 2015 to 2015
$225k
NIGMS NIH HHS R01 GM121499
6 · The paper itself

Abstract

Binding of a BMP to its cognate cell surface receptors is the initiating step in the BMP signaling cascade. Thus, knowing which BMP-receptor complexes form is vital for understanding the physiological activities of a particular BMP. Here, we describe a surface plasmon resonance (SPR)-based, high-throughput approach that allows fast identification and evaluation of BMP-receptor complexes. Briefly, the extracellular, BMP-binding domains of receptors are produced as human IgG1-Fc-fusion proteins. The Fc moiety enables simple capture of the Fc-receptor-fusion protein on the sensor chip, supports a highly reproducible, uniform approach of surface regeneration, and ensures full activity of the receptor moiety. BMPs are injected over the captured receptors at one concentration (approximately 60-100 nM), permitting stratification of high-affinity, medium-affinity, and low-affinity binders. Using this concentration range, equilibrium dissociation constants for high-affinity and medium-affinity binders can be estimated with good accuracy and with great precision from the single injection binding curves.

Indexed as

Biosensing TechniquesHigh-Throughput Screening AssaysBone Morphogenetic Protein ReceptorsBone Morphogenetic ProteinsProtein Interaction MappingSurface Plasmon ResonanceBone Morphogenetic Protein ReceptorsBone Morphogenetic ProteinsActivinBone morphogenetic proteinProtein–protein interaction sSurface plasmon resonanceTGF-β

Identifiers

PMID30414125
PMCPMC6319254
OpenAlexW2899661502

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.